Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT100 in repeated IVF failure
NCT01864356Phase 2Completed
- Sponsor
- Nora Therapeutics, Inc.
- Start
- May 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NT100 in in vitro fertilization failure, sponsored by Nora Therapeutics, Inc.. Started May 2013; status: completed.
02
Drugs
NT100
03
Conditions
in vitro fertilization failure
Beyond the preview
Go deeper on NCT01864356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864356.